These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12571825)

  • 1. Memory for new information as a cognitive marker of liability to Alzheimer's disease in a high risk group: a research note.
    Rice F; Abraham R; Rudrasingham V; Owen MJ; Williams J
    Int J Geriatr Psychiatry; 2003 Feb; 18(2):155-60. PubMed ID: 12571825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Object naming and semantic fluency among individuals with genetic risk for Alzheimer's disease.
    Miller KJ; Rogers SA; Siddarth P; Small GW
    Int J Geriatr Psychiatry; 2005 Feb; 20(2):128-36. PubMed ID: 15660408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Context-specific memory and apolipoprotein E (ApoE) epsilon 4: cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease.
    Levy JA; Bergeson J; Putnam K; Rosen V; Cohen R; Lalonde F; Mirza N; Linker G; Sunderland T
    J Int Neuropsychol Soc; 2004 May; 10(3):362-70. PubMed ID: 15147594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E and category fluency: evidence for reduced semantic access in healthy normal controls at risk for developing Alzheimer's disease.
    Rosen VM; Sunderland T; Levy J; Harwell A; McGee L; Hammond C; Bhupali D; Putnam K; Bergeson J; Lefkowitz C
    Neuropsychologia; 2005; 43(4):647-58. PubMed ID: 15716154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity in verbal memory: a marker of preclinical Alzheimer's disease?
    Wetter SR; Delis DC; Houston WS; Jacobson MW; Lansing A; Cobell K; Salmon DP; Bondi MW
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2006; 13(3-4):503-15. PubMed ID: 16887786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clustering and switching in semantic fluency: predictors of the development of Alzheimer's disease.
    Fagundo AB; López S; Romero M; Guarch J; Marcos T; Salamero M
    Int J Geriatr Psychiatry; 2008 Oct; 23(10):1007-13. PubMed ID: 18416452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological markers of dementia in patients with memory complaints.
    Guarch J; Marcos T; Salamero M; Blesa R
    Int J Geriatr Psychiatry; 2004 Apr; 19(4):352-8. PubMed ID: 15065228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotes.
    Caselli RJ; Reiman EM; Hentz JG; Osborne D; Alexander GE; Boeve BF
    Sleep; 2002 Jun; 25(4):447-53. PubMed ID: 12071547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
    Sager MA; Hermann B; La Rue A
    J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):245-9. PubMed ID: 16306248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive asymmetries associated with apolipoprotein E genotype in patients with Alzheimer's disease.
    Finton MJ; Lucas JA; Rippeth JD; Bohac DL; Smith GE; Ivnik RJ; Petersen RC; Graff-Radford NR
    J Int Neuropsychol Soc; 2003 Jul; 9(5):751-9. PubMed ID: 12901781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery].
    Barth S; Schönknecht P; Pantel J; Schröder J
    Fortschr Neurol Psychiatr; 2005 Oct; 73(10):568-76. PubMed ID: 16217697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
    Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L
    Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
    Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
    Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L
    Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.